Correlation Between Fubon MSCI and Alar Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Fubon MSCI and Alar Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fubon MSCI and Alar Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fubon MSCI Taiwan and Alar Pharmaceuticals, you can compare the effects of market volatilities on Fubon MSCI and Alar Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fubon MSCI with a short position of Alar Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fubon MSCI and Alar Pharmaceuticals.
Diversification Opportunities for Fubon MSCI and Alar Pharmaceuticals
0.02 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Fubon and Alar is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Fubon MSCI Taiwan and Alar Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alar Pharmaceuticals and Fubon MSCI is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fubon MSCI Taiwan are associated (or correlated) with Alar Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alar Pharmaceuticals has no effect on the direction of Fubon MSCI i.e., Fubon MSCI and Alar Pharmaceuticals go up and down completely randomly.
Pair Corralation between Fubon MSCI and Alar Pharmaceuticals
Assuming the 90 days trading horizon Fubon MSCI Taiwan is expected to under-perform the Alar Pharmaceuticals. But the etf apears to be less risky and, when comparing its historical volatility, Fubon MSCI Taiwan is 3.38 times less risky than Alar Pharmaceuticals. The etf trades about -0.08 of its potential returns per unit of risk. The Alar Pharmaceuticals is currently generating about 0.24 of returns per unit of risk over similar time horizon. If you would invest 12,650 in Alar Pharmaceuticals on December 4, 2024 and sell it today you would earn a total of 2,250 from holding Alar Pharmaceuticals or generate 17.79% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Fubon MSCI Taiwan vs. Alar Pharmaceuticals
Performance |
Timeline |
Fubon MSCI Taiwan |
Alar Pharmaceuticals |
Fubon MSCI and Alar Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Fubon MSCI and Alar Pharmaceuticals
The main advantage of trading using opposite Fubon MSCI and Alar Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fubon MSCI position performs unexpectedly, Alar Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alar Pharmaceuticals will offset losses from the drop in Alar Pharmaceuticals' long position.Fubon MSCI vs. Fubon Hang Seng | Fubon MSCI vs. Fubon SP Preferred | Fubon MSCI vs. Fubon NASDAQ 100 1X | Fubon MSCI vs. Fubon TWSE Corporate |
Alar Pharmaceuticals vs. First Copper Technology | Alar Pharmaceuticals vs. General Plastic Industrial | Alar Pharmaceuticals vs. Singtex Industrial Co | Alar Pharmaceuticals vs. Feng Ching Metal |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |